Published in Allergy on October 01, 1979
MICA polymorphism identified by whole genome array associated with NKG2D-mediated cytotoxicity in T-cell large granular lymphocyte leukemia. Haematologica (2010) 0.77
HLA-Cw Allele Frequency in Definite Meniere's Disease Compared to Probable Meniere's Disease and Healthy Controls in an Iranian Sample. Iran J Otorhinolaryngol (2016) 0.75
HL-A antigens and diabetes mellitus. Lancet (1974) 4.42
HL-A antigens and disease. Statistical and genetical considerations. Tissue Antigens (1974) 4.41
HLA and disease 1982--a survey. Immunol Rev (1983) 3.87
Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol (1995) 3.30
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
HL-A and disease associations--a survey. Transplant Rev (1975) 2.87
A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet (1999) 2.85
Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci U S A (1999) 2.83
Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group. Lancet (1997) 2.70
Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum (1999) 2.66
Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet (1973) 2.41
Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet (1995) 2.31
A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics (1994) 2.31
Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest (1999) 2.24
Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol (1998) 2.11
HL-A antigens and multiple sclerosis. Lancet (1972) 2.09
MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease. Transplant Rev (1975) 1.97
Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet (1997) 1.92
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum (1982) 1.83
HLA genotype distribution and genetic models of insulin-dependent diabetes mellitus. Ann Hum Genet (1981) 1.78
Genetics of HLA disease association. Annu Rev Genet (1981) 1.74
Human cell-mediated cytotoxicity against modified target cells is restricted by HLA. Nature (1977) 1.69
Studies of the HLA system and insulin-dependent diabetes mellitus. Diabetes Care (1980) 1.63
Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet (1998) 1.62
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol (1998) 1.50
Dual role of mannan-binding protein in infections: another case of heterosis? Eur J Immunogenet (1994) 1.50
Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc Natl Acad Sci U S A (1997) 1.47
Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens (2004) 1.47
The HL-A7 histocompatibility antigen in sarcoidosis in relation to tuberculin sensitivity. Tissue Antigens (1975) 1.45
HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus. Diabetologia (1981) 1.43
Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol (1988) 1.40
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40
[Transplantation. Blood, bone marrow and solid organs]. Ugeskr Laeger (2000) 1.39
Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci U S A (1998) 1.38
The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis Rheum (2000) 1.37
Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol (1988) 1.37
HLA--Dw4 and rheumatoid arthritis. Tissue Antigens (1979) 1.36
Diallelic polymorphism may explain variations of the blood concentration of mannan-binding protein in Eskimos, but not in black Africans. Eur J Immunogenet (1992) 1.35
Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32
Heterozygous expression of insulin-dependent diabetes mellitus (IDDM) determinants in the HLA system. Am J Hum Genet (1983) 1.25
Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3. Proc Natl Acad Sci U S A (1999) 1.22
Nomenclature for factors of the HLA system, 2000. Tissue Antigens (2001) 1.21
Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J Rheumatol (2000) 1.20
HLA and disease. Transplant Proc (1977) 1.19
HL-A in psoriasis vulgaris and in pustular psoriasis--population and family studies. Br J Dermatol (1974) 1.18
Nomenclature for factors of the HLA system, 1996. Tissue Antigens (1997) 1.18
Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide. Proc Natl Acad Sci U S A (1996) 1.14
Letter: HL-A and idiopathic Addison's disease. Lancet (1974) 1.14
Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. Eur J Immunol (1994) 1.14
The germline repertoire of T-cell receptor beta chain genes in patients with relapsing/remitting multiple sclerosis or optic neuritis. Immunogenetics (1990) 1.13
An HLA map of Europe. Hum Hered (1978) 1.13
HL-A antigens and diseases. I. Multiple sclerosis. Tissue Antigens (1973) 1.11
The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Genes Immun (2001) 1.11
MHC class II ligation induces CD58 (LFA-3)-mediated adhesion in human T cells. Exp Clin Immunogenet (1998) 1.10
HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens (1986) 1.08
The genetic susceptibility to insulin-dependent diabetes mellitus: combined segregation and linkage analysis. Genet Epidemiol (1985) 1.08
Letter: Lack of antigen response to myxoviruses in multiple sclerosis. Lancet (1973) 1.08
Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations. Clin Exp Immunol (1992) 1.08
Nomenclature for factors of the HLA system, 2000. Eur J Immunogenet (2001) 1.08
Letter: Salmonella arthritis and HL-A27. Lancet (1974) 1.07
Genetic studies of insulin-dependent diabetes mellitus: segregation and linkage analyses. Tissue Antigens (1982) 1.06
Importance of HLA-D antigens for the cooperation between human monocytes and T lymphocytes. Eur J Immunol (1978) 1.06
Genetics of the human HL-A transplantation system. Nature (1968) 1.06
NcoI restriction fragment length polymorphism (RFLP) of the tumour necrosis factor (TNF alpha) region in primary biliary cirrhosis and in healthy Danes. Scand J Immunol (1989) 1.06
Detection of HLA-D/DR-related DNA polymorphism in HLA-D homozygous typing cells. Proc Natl Acad Sci U S A (1983) 1.05
PGM3: HL-A is another linkage in man. Nat New Biol (1971) 1.04
HLA antigens in Graves' disease. Acta Endocrinol (Copenh) (1977) 1.04
The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules. Eur J Immunol (1998) 1.04
Humoral responses to Pneumocystis carinii in patients with acquired immunodeficiency syndrome and in immunocompromised homosexual men. J Infect Dis (1985) 1.04
Immunological studies in the acquired immunodeficiency syndrome. II. Active suppression or intrinsic defect--investigated by mixing AIDS cells with HLA-DR identical normal cells. Scand J Immunol (1986) 1.03
Association between an interleukin-13 promoter polymorphism and atopy. Eur J Immunogenet (2003) 1.03
Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics. Scand J Immunol (1997) 1.02
Cutting edge: TCR stimulation by antibody and bacterial superantigen induces Stat3 activation in human T cells. J Immunol (1999) 1.01
Multiple MLC (LD) determinants on the same HL-A haplotype. Transplant Proc (1973) 1.00
Histocompatibility determinants in multiple sclerosis. Transplant Rev (1975) 1.00
Human retinal pigment epithelial cell-induced apoptosis in activated T cells. Invest Ophthalmol Vis Sci (1998) 1.00
Typing for MLC determinants by means of LD-homozygous and LD-heterozygous test cells. Transplant Proc (1973) 1.00
On the orientation of the HL-A region and the PGM3 locus in the chromosome. Tissue Antigens (1972) 0.99
The HLA-DP polymorphism in Denmark investigated by local and international PLT reagents. Definition of two "new" DP antigens. Tissue Antigens (1986) 0.99
Recipient lymphocyte sensitivity to methylprednisolone affects cadaver kidney graft survival. Lancet (1986) 0.99
Immunological studies in acquired immunodeficiency syndrome. Functional studies of lymphocyte subpopulations. Scand J Immunol (1985) 0.98
MHC class II molecules regulate growth in human T cells. Exp Clin Immunogenet (1994) 0.98
Mixed lymphocyte cultures and HL-A identity in unrelated subjects. Nature (1970) 0.97
Concanavalin-A-induced suppressor lymphocytes in normal individuals. Scand J Immunol (1981) 0.97
Mannan binding lectin in rheumatoid arthritis. A longitudinal study. J Rheumatol (1998) 0.96
An update to HLA nomenclature, 2010. Bone Marrow Transplant (2010) 0.96
Two separate genes controlling stimulation in mixed lymphocyte reaction in man. Proc Natl Acad Sci U S A (1974) 0.96
Relative importance of Four and LA loci in determining mixed-lymphocyte reaction. Lancet (1971) 0.96
Association between genetic polymorphisms in the human interleukin-7 receptor alpha-chain and inhalation allergy. Int J Immunogenet (2007) 0.96
Immunological studies in sarcoidosis: a comparison of disease activity and various immunological parameters. Ann N Y Acad Sci (1976) 0.96
IL-6 gene polymorphism in rheumatoid arthritis, pauciarticular juvenile rheumatoid arthritis, systemic lupus erythematosus, and in healthy Danes. J Immunogenet (1989) 0.95
HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment. Ann Rheum Dis (1989) 0.94
HLA-DP antigens are involved in the susceptibility to multiple sclerosis. Tissue Antigens (1988) 0.94
Innate immunity: from plants to humans. Immunol Today (2000) 0.94